Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

InMode Ltd

INMB
Current price
9.61 USD +0.12 USD (+1.26%)
Last closed 23.75 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 1 907 668 224 USD
Yield for 12 month -33.06 %
Week
Month
Year
INMB
21.11.2021 - 28.11.2021

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel. Address: Tavor Building, Yokne'am, Israel, 2069206

Analytics

WallStreet Target Price

35.4 USD

P/E ratio

10.9143

Dividend Yield

Current Year

+454 271 000 USD

Last Year

+357 565 000 USD

Current Quarter

+123 112 000 USD

Last Quarter

+136 081 000 USD

Current Year

+380 786 000 USD

Last Year

+303 973 000 USD

Current Quarter

+102 976 000 USD

Last Quarter

+114 027 000 USD

Key Figures INMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 205 032 992 USD
Operating Margin TTM 37.7 %
PE Ratio 10.9143
Return On Assets TTM 18.61 %
PEG Ratio 2.9004
Return On Equity TTM 29.3 %
Wall Street Target Price 35.4 USD
Revenue TTM 498 838 016 USD
Book Value 8.64 USD
Revenue Per Share TTM 6 USD
Dividend Share
Quarterly Revenue Growth YOY 1.6 %
Dividend Yield
Gross Profit TTM 380 786 000 USD
Earnings Share 2.1 USD
Diluted Eps TTM 2.1 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY -6.9 %
Profit Margin 36.18 %

Dividend Analytics INMB

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History INMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 2:1
Payout Ratio
Last Split Date 01.10.2021
Dividend Date

Stock Valuation INMB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 10.9143
Forward PE 14.5138
Enterprise Value Revenue 6.2073
Price Sales TTM 6.9857
Enterprise Value EBITDA 13.8906
Price Book MRQ 6.2159

Financials INMB

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators INMB

For 52 weeks

18.57 USD 48.25 USD
50 Day MA 24.57 USD
Shares Short Prior Month 8 929 375
200 Day MA 33.57 USD
Short Ratio 3.07
Shares Short 9 570 125
Short Percent 12.44 %